Sanofi India Limited has informed the Exchange regarding Cessation of Mr. Rachid Ayari as the Interim Managing Director of the company w.e.f. October 26, 2025.
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi India has informed the stock exchange that Mr. Rachid Ayari ceased to be the Interim Managing Director of the company with effect from October 26, 2025. He was holding the position on an interim basis and his tenure has now ended. No details of a permanent replacement have been mentioned in this filing. Sanofi India is the Indian subsidiary of the global pharmaceutical company Sanofi.
This is a routine leadership transition as Mr. Ayari was serving in an interim capacity. Shareholders should watch for an announcement on the appointment of a permanent Managing Director, which will be a more material event for the company's strategic direction.